Zhou Gan / Associate Professor
Member of the Professional Committee on Ethics of Drug Clinical Trials, Chinese Pharmaceutical Association
Doctor of Medicine, associate professor, master supervisor. Member of the Professional Committee on Ethics of Drug Clinical Trials of the Chinese Pharmaceutical Association, Member of the Professional Committee of Pharmacogenomics of the Chinese Pharmacological Society, Standing Member of the Youth Committee of the Pharmacokinetics Committee of the Chinese Pharmacological Society, Youth Member of the China Federation of Drug Clinical Trial Institutions, Director of the Hunan Pharmaceutical Association, Hunan Member of the Provincial Pharmacological Society, member of the Pharmacogenomics Professional Committee of the Hunan Pharmaceutical Association, member of the Clinical Pharmacology Professional Committee of the Hunan Medical Association, national GCP verification expert, Hunan high-tech review expert, Changsha City Science and Technology Plan review expert. In 2001, he graduated from the Department of Clinical Medicine, Xiangya Medical College, Central South University. After graduation, he worked as a teaching researcher at the Institute of Clinical Pharmacology, Central South University. He obtained a master's degree in pharmacy and a doctorate degree in clinical pharmacology in 2006 and 2009, respectively. During the period, he conducted joint doctoral training and research work at the Renji Research Center of the University of Kansas in the United States and the Clinical Pharmacology Center of Inje University in South Korea. In 2009, he served as the deputy director of the National Training Center for Clinical Medicine of Central South University. In 2011, he was transferred to Changsha Municipal Science and Technology Bureau as the Deputy Director of the Overseas Division. In 2015, he was transferred to the drug clinical trial management organization of Xiangya Hospital of Central South University. In 2016, he served as the deputy director of the agency office and deputy director of the Phase I clinical research center of Xiangya Hospital.
Mainly engaged in new drug clinical trials and pharmacogenomics research. Presided over and participated in 4 National Natural Science Foundation projects; presided over 2 major national scientific and technological special sub-projects of "Major new drug creation", 1 national major scientific and technological sub-project of "Major chronic diseases"; presided over and participated in national and international scientific research projects and new drugs More than 50 research and development projects; 5 provincial and ministerial science and technology awards, 46 SCI papers have been published, 1 authorized patent, and 2 books have been edited.